Explore tweets tagged as #DXCM
@ChartsLector
ChartsLector
12 hours
$DXCM
0
0
0
@roboinv
RoboInvest Capital Ⓡ
2 months
6️⃣ $DXCM — DexCom 🇺🇸 Ⓡ 🧠 Digital Health & Wearable Data 📊 Entry (Nov 1): $58.22 DexCom is reshaping modern health monitoring. Its continuous glucose sensors deliver real-time metabolic data, while AI-driven insights help patients and clinicians anticipate trends before they
0
0
2
@william9in
Willy👽
14 hours
$DXCM looking good.
@william9in
Willy👽
3 days
$DXCM
0
0
0
@Praestans_TR
𝐏𝐫𝐚𝐞𝐬𝐭𝐚𝐧𝐬
2 months
$dxcm It's time to buy
0
0
9
@william9in
Willy👽
3 days
$DXCM
0
0
2
@Dimogotoptions
Dimo
14 days
$DXCM -- monthly Price is now retesting the pivot zone. Looking for a rejection indicating a bearish shift of structure for lower pricing.
0
0
2
@thestockblog
THE STOCK BLOG
1 month
$DXCM - here is what could happen...
1
0
0
@oszn180
Omar
2 days
0
0
3
@AIStockSavvy
Hardik Shah
1 month
$DXCM | 𝐃𝐞𝐱𝐂𝐨𝐦: Leerink Partners reiterates Outperform, raises 𝐏𝐓 𝐭𝐨 $𝟗𝟐 Analyst sees improving sensor complaint trends and attractive 2026 risk/reward, backed by conservative guidance and competitive tailwinds.
0
0
7
@Carson2Money
Carson
6 hours
$DXCM Consolidating since 2020. Since then: Revenue: 2020: 1.9B 2021: 2.4B 2022: 2.9B 2023: 3.6B 2024: 4.0B 2025: 4.5B (through 3 Qtrs) Interested in playing the ST bull cycle. But LT entry probably in a few months or so.
@Carson2Money
Carson
7 hours
My jaw just dropped looking at $DXCM
1
0
2
@TigerLineTrades
Tiger Line Trading
11 days
$DXCM BIG LEVEL ON THE DAILY HERE...
1
0
6
@pernasresearch
Pernas Research
1 month
Accidently deleted this tweet: $DXCM still no bulls have commented. We see vulnerabilities regarding new CMS bidding putting pricing pressure on CGM devices along with GLP-1 penetration presenting headwinds.
3
0
8
@FL0WG0D
Flow God
17 days
$DXCM - Small $25K Call buyer
1
1
22
@MartyChargin
Marty Chargin
11 days
$DXCM ... Dexcom guides Q4 revs slightly above consensus; guides FY26 revs in-line (67.40) Co issues upside guidance for Q4 (Dec), sees Q4 (Dec) revs of $1.26 bln vs. $1.24 bln FactSet Consensus. US revenue is expected to be up 11% yr/yr to approximately $892 mln. International
0
2
4
@StockPicksNYC
Stock Picks NYC
9 days
$ADHC Very attractive at 1M market cap Quick DD •GlucoGuard, diabetes medical device •FDA Breakthrough Device pending •Partnership with $DXCM a $27B co •Hedgefund backing •CFA Analyst coverage •Impressive team, including former FDA official Stephen Weber •University of
0
6
20
@Carson2Money
Carson
7 hours
My jaw just dropped looking at $DXCM
0
0
2
@SAJ20000
د. سلطان بن جريس
26 days
الله يبارك لكل من استثمر. 👌🏽 $DXCM
@SAJ20000
د. سلطان بن جريس
2 months
مساء الخير جميعاً، اعتقد بوجود فرصة الاستثمارية في شركة DexCom – $DXCM ، وذلك بالاعتماد على البيانات والتحليل الفني والمالي، (مع التأكيد أنها ليست توصية استثمارية، وأن على كل مستثمر القيام بب��ثه الخاص قبل اتخاذ أي قرار.)🚨 تُعد DexCom أحد أهم اللاعبين العالميين في سوق أجهزة
2
2
8
@NCarolinaTrader
NorthCarolinaTrader
2 months
$DXCM … I can not imagine a public company with a more crappy product. 1980s like technology that frequently does not work properly. Hides behind patents to prevent competitors from coming to mkt with vast improvements. SELL.
0
0
0
@MrStonkington
Mr. Stonkington
6 hours
1/22 Darkpool Bonus screen shots included. These are posted daily in our discord Large darkpool $SBUX $CORZ $BABA $LI $RSP $ASHR $MCHP $USB $EQT $PSKY $DXCM
0
0
4